Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
This study tested whether osseous integration into poly (ε-caprolactone) (PCL) bioplastic scaffolds with fully-interconnecting 155 ± 8 μm pores is enhanced by an adhesive, non-inflammatory 99% degree of deacetylation (DDA) chitosan coating (99-PCL), or further incorporation of pro-inflammatory 83% D...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/337e6ff2ce3243578603850bfdbb4e6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:337e6ff2ce3243578603850bfdbb4e6f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:337e6ff2ce3243578603850bfdbb4e6f2021-11-28T04:35:38ZChitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size2452-199X10.1016/j.bioactmat.2021.09.012https://doaj.org/article/337e6ff2ce3243578603850bfdbb4e6f2022-04-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2452199X21004291https://doaj.org/toc/2452-199XThis study tested whether osseous integration into poly (ε-caprolactone) (PCL) bioplastic scaffolds with fully-interconnecting 155 ± 8 μm pores is enhanced by an adhesive, non-inflammatory 99% degree of deacetylation (DDA) chitosan coating (99-PCL), or further incorporation of pro-inflammatory 83% DDA chitosan microparticles (83-99-PCL) to accelerate angiogenesis. New Zealand White rabbit osteochondral knee defects were press-fit with PCL, 99-PCL, 83-99-PCL, or allowed to bleed (drill-only). Between day 1 and 6 weeks of repair, drill-only defects repaired by endochondral ossification, with an 8-fold higher bone volume fraction (BVF) versus initial defects, compared to a 2-fold (99-PCL), 1.1-fold (PCL), or 0.4-fold (83-99-PCL) change in BVF. Hematoma innate immune cells swarmed to 83-99-PCL, elicited angiogenesis throughout the pores and induced slight bone resorption. PCL and 99-PCL pores were variably filled with cartilage or avascular mesenchyme near the bone plate, or angiogenic mesenchyme into which repairing trabecular bone infiltrated up to 1 mm deep. More repair cartilage covered the 99-PCL scaffold (65%) than PCL (18%) or 83-99-PCL (0%) (p < 0.005). We report the novel finding that non-inflammatory chitosan coatings promoted cartilage infiltration into and over a bioplastic scaffold, and were compatible with trabecular bone integration. This study also revealed that in vitro osteogenesis assays have limited ability to predict osseous integration into porous scaffolds, because (1) in vivo, woven bone integrates from the leading edge of regenerating trabecular bone and not from mesenchymal cells adhering to scaffold surfaces, and (2) bioactive coatings that attract inflammatory cells induce bone resorption.Caroline D. HoemannJavier Rodríguez GonzálezJessica Guzmán-MoralesGaoping ChenEbrahim Jalali DilBasil D. FavisKeAi Communications Co., Ltd.articleBone tissue engineeringCartilage tissue engineeringHematomaChitosanAngiogenesisOsteogenesisMaterials of engineering and construction. Mechanics of materialsTA401-492Biology (General)QH301-705.5ENBioactive Materials, Vol 10, Iss , Pp 430-442 (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Bone tissue engineering Cartilage tissue engineering Hematoma Chitosan Angiogenesis Osteogenesis Materials of engineering and construction. Mechanics of materials TA401-492 Biology (General) QH301-705.5 |
spellingShingle |
Bone tissue engineering Cartilage tissue engineering Hematoma Chitosan Angiogenesis Osteogenesis Materials of engineering and construction. Mechanics of materials TA401-492 Biology (General) QH301-705.5 Caroline D. Hoemann Javier Rodríguez González Jessica Guzmán-Morales Gaoping Chen Ebrahim Jalali Dil Basil D. Favis Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
description |
This study tested whether osseous integration into poly (ε-caprolactone) (PCL) bioplastic scaffolds with fully-interconnecting 155 ± 8 μm pores is enhanced by an adhesive, non-inflammatory 99% degree of deacetylation (DDA) chitosan coating (99-PCL), or further incorporation of pro-inflammatory 83% DDA chitosan microparticles (83-99-PCL) to accelerate angiogenesis. New Zealand White rabbit osteochondral knee defects were press-fit with PCL, 99-PCL, 83-99-PCL, or allowed to bleed (drill-only). Between day 1 and 6 weeks of repair, drill-only defects repaired by endochondral ossification, with an 8-fold higher bone volume fraction (BVF) versus initial defects, compared to a 2-fold (99-PCL), 1.1-fold (PCL), or 0.4-fold (83-99-PCL) change in BVF. Hematoma innate immune cells swarmed to 83-99-PCL, elicited angiogenesis throughout the pores and induced slight bone resorption. PCL and 99-PCL pores were variably filled with cartilage or avascular mesenchyme near the bone plate, or angiogenic mesenchyme into which repairing trabecular bone infiltrated up to 1 mm deep. More repair cartilage covered the 99-PCL scaffold (65%) than PCL (18%) or 83-99-PCL (0%) (p < 0.005). We report the novel finding that non-inflammatory chitosan coatings promoted cartilage infiltration into and over a bioplastic scaffold, and were compatible with trabecular bone integration. This study also revealed that in vitro osteogenesis assays have limited ability to predict osseous integration into porous scaffolds, because (1) in vivo, woven bone integrates from the leading edge of regenerating trabecular bone and not from mesenchymal cells adhering to scaffold surfaces, and (2) bioactive coatings that attract inflammatory cells induce bone resorption. |
format |
article |
author |
Caroline D. Hoemann Javier Rodríguez González Jessica Guzmán-Morales Gaoping Chen Ebrahim Jalali Dil Basil D. Favis |
author_facet |
Caroline D. Hoemann Javier Rodríguez González Jessica Guzmán-Morales Gaoping Chen Ebrahim Jalali Dil Basil D. Favis |
author_sort |
Caroline D. Hoemann |
title |
Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
title_short |
Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
title_full |
Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
title_fullStr |
Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
title_full_unstemmed |
Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
title_sort |
chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size |
publisher |
KeAi Communications Co., Ltd. |
publishDate |
2022 |
url |
https://doaj.org/article/337e6ff2ce3243578603850bfdbb4e6f |
work_keys_str_mv |
AT carolinedhoemann chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize AT javierrodriguezgonzalez chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize AT jessicaguzmanmorales chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize AT gaopingchen chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize AT ebrahimjalalidil chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize AT basildfavis chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize |
_version_ |
1718408309241806848 |